Pay in 4 interest-free payments of $30.25 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Necrostatin-34 (Nec-34
InChi: InChI=1S/C29H29F3N8O/c1-19-26(38-28-34-9-7-25(37-28)21-4-3-8-33-16-21)15-23(17-35-19)36-27(41)20-5-6-22(24(14-20)29(30
Miglustat is used to treat adults with mild-to-moderate Type I Gaucher disease and it is the first treatment to be approved for patients with Niemann–Pick type C disease
Selective Inhibitor of the Protein Methyltransferase DOT1L for Use in the Treatment of MLL-Rearranged Leukemia
Brexpiprazole S-oxide D8 Size:Contact [email protected] for quotation Necrostatin-34 (Nec-34Brexpiprazole S oxide D8 (DM 3411 D8) is a deuterium labeled Brexpiprazole S oxide. Brexpiprazole S oxide is a main metabolite of Brexpiprazole and is metabolized by cytochrome P450 3A4 (CYP3A4). Brexpiprazole is an atypical antipsychotic agent and a partial agonist of human 5 HT1A and dopamine receptor with Kis of 0. 12 nM and 0. 3 nM, respectively. Brexpiprazole is also a 5 HT2A receptor antagonist with a Ki of 0. 47 nM. Product information
US$ 100.00
US$ 1567.00
US$ 2093.50
US$ 5241.00
US$ 1692.00
US$ 100.00
US$ 1144.00
US$ 100.00
US$ 100.00